BDBM235826 US9364459, N

SMILES COc1cc(cc(OC)c1OC)C1=C(C(=O)NC1=O)c1cn(CCC[NH+]2CC[NH+](C)CC2)c2ccccc12

InChI Key InChIKey=UTNNKNOWQOKPOE-UHFFFAOYSA-P

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 235826   

TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz

US Patent
LigandPNGBDBM235826(US9364459, N)
Affinity DataIC50:  2.83E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGlycogen synthase kinase-3 beta(Human)
Johannes Gutenberg-UniversitäT Mainz

US Patent
LigandPNGBDBM235826(US9364459, N)
Affinity DataIC50:  3.24E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg-UniversitäT Mainz

US Patent
LigandPNGBDBM235826(US9364459, N)
Affinity DataIC50: >1.00E+4nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent